Skip to main content

GenData to Provide Celera Dx with DNA Samples for Autoimmune Disease Study

NEW YORK, Sept. 15 (GenomeWeb News) - GenData will provide Celera Diagnostics with DNA samples and clinical information for a study aimed at identifying genetic markers of an autoimmune disease, the company said today.

 

GenData, based in Salt Lake City, Utah, will give Celera access to DNA samples and clinical data from affected individuals, as well as to samples from matched controls.

 

GenData provides commercial access to the Utah Population Database, which contains more than seven million records, including genealogical records, population records, and vital statistics linked to medical information. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.